Cold chain and time-critical logistics
Radioactive medicines keep losing strength from the moment they are made, so a doctor prescribes a specific amount to arrive at a specific time. If a flight is delayed, an airline refuses the cargo, or customs holds the package for even a few hours, the dose can decay below the amount a patient needs and has to be thrown away.
Overview
Because radioactive decay cannot be paused, every radiopharmaceutical shipment is ordered as an activity calibrated to a specific date and time, with the manufacturer dispensing extra margin so the prescribed activity still holds when the patient is dosed. For the shortest-lived isotopes the arithmetic is unforgiving: molybdenum-99, with a 66-hour half-life, loses about 22% of its activity to a single day's transport delay. A missed delivery window is not simply a late shipment -- the product is unusable and cannot be replaced from any stockpile.
Most radiopharmaceutical shipments travel as Class 7 dangerous goods under IATA and national transport rules, on top of any temperature control (commonly 2-8°C) the specific product needs, and this dual compliance burden restricts which carriers and routes are available. Some major airlines refuse Class 7 cargo outright, individual pilots have refused loads once they see radioactive labelling, and flights that do accept it often cap the total transport index (radiation level) permitted per aircraft. A 2026 survey of six English-speaking Southern African Development Community countries found customs clearance delays of up to a day reported in South Africa, Zambia, Namibia, Tanzania and Mauritius, with reported order-to-delivery lead times ranging from a few days (regional generator shipments) to about a month for products sourced from further afield.
The IAEA and ICAO have responded with a formal denial-and-delay-of-shipment reporting mechanism and national focal points to track and resolve recurring blockages, and IATA now requires shippers to hold specific Class 7 certification, but the underlying constraint -- a short, physics-set delivery window intersecting with an inconsistent, carrier-by-carrier and country-by-country regulatory patchwork -- has not been resolved.
- Radioactive decay is continuous and irreversible, so there is no buffer stock to fall back on if a shipment is delayed anywhere in the chain.
- Radiopharmaceuticals must simultaneously meet Class 7 radioactive-material transport rules and, for many products, refrigerated cold-chain requirements, a combination few carriers are equipped or willing to handle.
- Some airlines and individual crews decline Class 7 cargo outright, narrowing available routes, and remaining carriers cap how much transport-index (radiation level) cargo they will carry per flight.
- Customs procedures for radioactive material are inconsistently applied across countries, and staff at many border posts have limited familiarity with the specific documentation required.
- IAEA/ICAO joint denial-and-delay-of-shipment (DoS) reporting framework, with each IAEA member state encouraged to nominate a National Focal Point to resolve recurring blockages.
- IATA Class 7 shipper certification requirements intended to standardise documentation and reduce carrier refusals.
- Specialised radiopharma logistics providers building dedicated Class 7 lanes and direct routing to minimise transit hours for short-half-life products.
- Customs staff education programmes proposed in regional supply-chain studies to reduce clearance delays for time-critical shipments.
Similar pages
not linked directly; found by shared links- CompanyANSTO (Australian Nuclear Science and Technology Organisation)
Shares Molybdenum-99 supply, Molybdenum-99, Radiopharmacy and cyclotron networks, Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225).
- IdeaIn-house hospital radiopharmacy compounding to cut dose waste
Shares Regional radiopharmacy hubs and harmonised transport rules for short-lived isotopes, Radiopharmacy and cyclotron networks, Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225).
- BottleneckReimbursement and coding for radiopharmaceuticals
Shares Molybdenum-99 supply, Site readiness and referral pathway delays, PET tracer manufacturing and distribution, Molybdenum-99.
- CompanySHINE Technologies
Shares Molybdenum-99 supply, Molybdenum-99, Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225).
- CompanyNTP Radioisotopes
Shares Molybdenum-99 supply, Molybdenum-99, Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225).
- CompanyNordion (Sotera Health)
Shares Molybdenum-99 supply, Molybdenum-99.
- CompanyIRE (Institut national des Radioéléments)
Shares Molybdenum-99 supply, Molybdenum-99, Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225).
- CompanyNorthStar Medical Radioisotopes
Shares Molybdenum-99 supply, Molybdenum-99, Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225).